Our data show that the levels of PD1 expression of CD4+ and CD8+ T cells and PDL-1 expression on monocytes and neutrophils are significantly increased at ToD as compared to control. This evidence concerns the gene PDCD1 and terminal osseous dysplasia-pigmentary defects syndrome.